Wallace Capital Management Inc. Sells 3,400 Shares of The Clorox Company (NYSE:CLX)

Wallace Capital Management Inc. reduced its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 25.3% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 10,054 shares of the company's stock after selling 3,400 shares during the period. Clorox comprises about 0.2% of Wallace Capital Management Inc.'s investment portfolio, making the stock its 29th biggest position. Wallace Capital Management Inc.'s holdings in Clorox were worth $1,633,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Brooklyn Investment Group lifted its position in shares of Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company's stock worth $25,000 after purchasing an additional 95 shares in the last quarter. Redwood Park Advisors LLC bought a new position in Clorox in the 4th quarter valued at $26,000. Millstone Evans Group LLC acquired a new stake in shares of Clorox in the 4th quarter valued at $31,000. Asset Planning Inc bought a new stake in shares of Clorox during the fourth quarter worth $32,000. Finally, GKV Capital Management Co. Inc. acquired a new position in shares of Clorox during the fourth quarter valued at $32,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Stock Performance

Shares of Clorox stock opened at $134.81 on Tuesday. The stock's fifty day simple moving average is $140.80 and its 200 day simple moving average is $153.09. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The company has a market capitalization of $16.62 billion, a PE ratio of 36.83, a PEG ratio of 2.62 and a beta of 0.60. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing analysts' consensus estimates of $1.57 by ($0.12). Clorox had a return on equity of 316.87% and a net margin of 6.38%. The business had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.74 billion. During the same period in the prior year, the business earned $1.71 EPS. The company's revenue for the quarter was down 8.0% compared to the same quarter last year. On average, research analysts predict that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, May 9th. Investors of record on Wednesday, April 23rd were issued a dividend of $1.22 per share. The ex-dividend date of this dividend was Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.62%. Clorox's payout ratio is 87.61%.

Analysts Set New Price Targets

A number of analysts recently commented on the company. DA Davidson lowered their price objective on Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a research report on Wednesday, February 5th. Royal Bank of Canada reiterated a "sector perform" rating and set a $150.00 price target on shares of Clorox in a research report on Thursday, January 30th. Barclays cut their price objective on shares of Clorox from $134.00 to $129.00 and set an "underweight" rating on the stock in a report on Wednesday, May 7th. JPMorgan Chase & Co. lowered their target price on shares of Clorox from $151.00 to $144.00 and set a "neutral" rating for the company in a report on Tuesday, May 6th. Finally, Wells Fargo & Company dropped their target price on shares of Clorox from $145.00 to $142.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. Three equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has issued a buy rating to the company's stock. According to MarketBeat, Clorox presently has a consensus rating of "Hold" and an average target price of $151.23.

Insider Activity at Clorox

In other news, Director Pierre R. Breber purchased 4,000 shares of the company's stock in a transaction on Wednesday, May 7th. The shares were purchased at an average price of $136.57 per share, with a total value of $546,280.00. Following the purchase, the director now directly owns 4,000 shares of the company's stock, valued at $546,280. This trade represents a ∞ increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 0.57% of the stock is currently owned by insiders.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.